← SynDRA
TARAFENACIN
SynDRA canonical compound SYN0027049 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CHRM3 |
| Mechanism of action | acetylcholine receptor antagonist |
All known targets
Mechanisms of action (all sources)
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- acetylcholine receptor antagonist
Cross-references
Synonyms
- Tarafenacine
- Tarafenacina
- Svt-40776
- SVT-40776
- Muscarinic M3 receptor antagonist (overactive bladder), SALVAT
- Tarafenacin [INN]
- UNII-LDV98UN52Y
- tarafenacina
- tarafenacine
- LDV98UN52Y
- TARAFENACIN [WHO-DD]
- tarafenacinum
- RefChem:187440
- Tarafenacin(SVT-40776)
- orb1706580
- SCHEMBL2278264
- EX-A209
- UXZDMXYRRQJIBJ-IBGZPJMESA-N
- BDBM50344283
- AKOS030526801
- AC-30285
- HY-14825
- T16990
- BRD-K59390331-045-01-5
Look up TARAFENACIN in the interactive SynDRA portal →